Armies of Pestilence: CNS Infections as Potential Weapons of Mass Destruction

References

1. 1.↵
   1. Dembek ZF

   2. Martin JW,
   3. Christopher GW,
   4. Eitzen EM

   . History of biological weapons: from poisoned darts to intentional epidemics. In: Dembek ZF, ed. Medical Aspects of Biological Warfare. Washington, DC: Borden Institute; 2007:1–20
2. 2.↵
   2. Croddy E

   . Chemical and Biological Warfare: A Comprehensive Survey for the Concerned Citizen. New York: Copernicus Books; 2002
3. 3.↵
   2. Manchee RJ,
   3. Broster MG,
   4. Stagg AJ, et al

   . Formaldehyde solution effectively inactivates spores of Bacillus anthracis on the Scottish island of Gruinard. Appl Environ Microbiol 1994;60:4167–71

   Abstract/FREE Full Text
4. 4.↵
   2. Cook MS,
   3. Woolf AF

   . Preventing proliferation of biological weapons: US assistance to the former Soviet states. Published April 10, 2002. http://oai.dtic.mil/oai/oai?verb=getRecord&metadataPrefix=html&identifier=ADA454722. Accessed August 1, 2014.
5. 5.↵
   PBS: American Experience. The Living Weapon. http://www.pbs.org/wgbh/americanexperience/features/transcript/weapon-transcript/. Accessed August 1, 2014.
6. 6.↵
   2. Meselson M,
   3. Guillemin J,
   4. Hugh-Jones M, et al

   . The Sverdlovsk anthrax outbreak of 1979. Science 1994;266:1202–08

   Abstract/FREE Full Text
7. 7.↵
   2. Abramova FA,
   3. Grinberg LM,
   4. Yampolskaya OV, et al

   . Pathology of inhalational anthrax in 42 cases from the Sverdlovsk outbreak of 1979. Proc Natl Acad Sci U S A 1993;90:2291–94

   Abstract/FREE Full Text
8. 8.↵
   2. Ragg V

   . Russia: anthrax in the Urals. Lancet 1992;339:419–20

   PubMed
9. 9.↵
   2. Takahashi H,
   3. Keim P,
   4. Kaufmann AF, et al

   . Bacillus anthracis bioterrorism incident, Kameido, Tokyo, 1993. Emerg Infect Dis 2004;10:117–20

   CrossRefPubMed
10. 10.↵
    2. Jernigan JA,
    3. Stephens DS,
    4. Ashford DA, et al

    . Bioterrorism-related inhalational anthrax: the first 10 cases reported in the United States. Emerg Infect Dis 2001;7:933–44

    CrossRefPubMedWeb of Science
11. 11.↵
    2. Jernigan DB,
    3. Raghunathan PL,
    4. Bell BP, et al

    . Investigation of bioterrorism-related anthrax, United States, 2001: epidemiologic findings. Emerg Infect Dis 2002;8:1019–28

    CrossRefPubMedWeb of Science
12. 12.↵
    2. Dixon TC,
    3. Meselson M,
    4. Guillemin J, et al

    . Anthrax. N Engl J Med 1999;341:815–26

    CrossRefPubMedWeb of Science
13. 13.↵
    1. Dembek ZF

    2. Purcell BK,
    3. Worsham PL,
    4. Friedlander AM

    . Anthrax. In: Dembek ZF, ed. Medical Aspects of Biological Warfare. Washington, DC: Borden Institute; 2007:69–90
14. 14.↵
    2. Ramsay CN,
    3. Stirling A,
    4. Smith J, et al

    . An outbreak of infection with Bacillus anthracis in injecting drug users in Scotland. Euro Surveill 2010;15:pii:19465
15. 15.↵
    2. Palmateer NE,
    3. Ramsay CN,
    4. Browning L, et al

    . Anthrax infection among heroin users in Scotland during 2009–2010: a case-control study by linkage to a national drug treatment database. Clin Infect Dis 2012;55:706–10

    Abstract/FREE Full Text
16. 16.↵
    2. Abbara A,
    3. Brooks T,
    4. Taylor GP, et al

    . Lessons for control of heroin-associated anthrax in Europe from 2009–2010 Outbreak Case Studies, London, UK. Emerg Infect Dis 2014;20:1115–22

    PubMed
17. 17.↵
    2. Brachman PS

    . Inhalation anthrax. Ann N Y Acad Sci 1980;353:83–93

    CrossRefPubMed
18. 18.↵
    2. Ketai L,
    3. Alrahji AA,
    4. Hart B, et al

    . Radiologic manifestations of potential bioterrorist agents of infection. AJR Am J Roentgenol 2003;180:565–75

    CrossRefPubMedWeb of Science
19. 19.↵
    National Services Scotland on behalf of the National Anthrax Outbreak Control Team. An outbreak of anthrax among drug users in Scotland, December 2009 to December 2010. December 2011. http://www.documents.hps.scot.nhs.uk/giz/anthrax-outbreak/anthrax-outbreak-report-2011-12.pdf. Accessed April 2, 2014.
20. 20.↵
    2. Tahernia AC,
    3. Hashemi G

    . Survival in anthrax meningitis. Pediatrics 1972;50:329–33

    Abstract/FREE Full Text
21. 21.↵
    2. Kim HJ,
    3. Jun WB,
    4. Lee SH, et al

    . CT and MR findings of anthrax meningoencephalitis: report of two cases and review of the literature. AJNR Am J Neuroradiol 2001;22:1303–05

    Abstract/FREE Full Text
22. 22.↵
    2. Yildirim H,
    3. Kabakus N,
    4. Koc M, et al

    . Meningoencephalitis due to anthrax: CT and MR findings. Pediatr Radiol 2006;36:1190–93

    CrossRefPubMed
23. 23.↵
    2. Booth MG,
    3. Hood J,
    4. Brooks TJ, et al

    . Anthrax infection in drug users. Lancet 2010;375:1345–46

    PubMedWeb of Science
24. 24.↵
    2. Hendricks KA,
    3. Wright ME,
    4. Shadomy SV, et al

    . Centers for Disease Control and Prevention expert panel meetings on prevention and treatment of anthrax in adults. Emerg Infect Dis 2014;20 doi: 10.3201/eid2002.130687.
25. 25.↵
    2. Tucker JB

    . Scourge: The Once and Future Threat of Smallpox. New York: Atlantic Monthly Press; 2001
26. 26.↵
    2. Inglesby TV,
    3. Dennis DT,
    4. Henderson DA, et al

    . Plague as a biological weapon: medical and public health management—Working Group on Civilian Biodefense. JAMA 2000;283:2281–90

    CrossRefPubMedWeb of Science
27. 27.↵
    2. Bray RS

    . Armies of Pestilence: The Impact of Disease on History. Cambridege: James Clarke and Co; 2004
28. 28.↵
    2. Becker TM,
    3. Poland JD,
    4. Quan TJ, et al

    . Plague meningitis: a retrospective analysis of cases reported in the United States, 1970–1979. West J Med 1987;147:554–57

    PubMedWeb of Science
29. 29.↵
    2. Martin AR,
    3. Hurtado FP,
    4. Plessala RA, et al

    . Plague meningitis: a report of three cases in children and review of the problem. Pediatrics 1967;40:610–16

    Abstract/FREE Full Text
30. 30.↵
    2. Jawetz E,
    3. Meyer KF

    . The behaviour of virulent and avirulent P. pestis in normal and immune experimental animals. J Infect Dis 1944;74:1–13

    FREE Full Text
31. 31.↵
    2. Hofinger DM,
    3. Cardona L,
    4. Mertz GJ, et al

    . Tularemic meningitis in the United States. Arch Neurol 2009;66:523–27

    CrossRefPubMed
32. 32.↵
    2. Lovell VM,
    3. Cho CT,
    4. Lindsey NJ, et al

    . Francisella tularensis meningitis: a rare clinical entity. J Infect Dis 1986;154:916–18

    FREE Full Text
33. 33.↵
    2. van de Beek D,
    3. Steckelberg JM,
    4. Marshall WF, et al

    . Tularemia with brain abscesses. Neurology 2007;68:531–31

    CrossRef
34. 34.↵
    2. Anderson A,
    3. Bijlmer H,
    4. Fournier PE, et al

    . Diagnosis and management of Q fever–United States, 2013: recommendations from CDC and the Q Fever Working Group. MMWR Recomm Rep 2013;62(RR-03):1–30

    PubMed
35. 35.↵
    2. Schattner A,
    3. Kushnir M,
    4. Zhornicky T, et al

    . Lymphocytic meningitis as the sole manifestation of Q fever. Postgrad Med J 1993;69:636–37

    Abstract/FREE Full Text
36. 36.↵
    2. Kofteridis DP,
    3. Mazokopakis EE,
    4. Tselentis Y, et al

    . Neurological complications of acute Q fever infection. Eur J Epidemiol 2004;19:1051–54

    CrossRefPubMedWeb of Science
37. 37.↵
    2. Bernit E,
    3. Pouget J,
    4. Janbon F, et al

    . Neurological involvement in acute Q fever: a report of 29 cases and review of the literature. Arch Intern Med 2002;162:693–700

    CrossRefPubMedWeb of Science
38. 38.↵
    2. Pappas G,
    3. Akritidis N,
    4. Bosilkovski M, et al

    . Brucellosis. N Engl J Med 2005;352:2325–36

    CrossRefPubMedWeb of Science
39. 39.↵
    1. Dembek ZF

    2. Purcell BK,
    3. Hoover DL,
    4. Friedlander AM

    . Brucellosis. In: Dembek ZF, ed. Medical Aspects of Biological Warfare. Washington, DC: Borden Institute; 2007:185–98
40. 40.↵
    2. Bilen Ş,
    3. Güneş HN,
    4. Saka M, et al

    . Four different clinical manifestations of neurobrucellosis (case reports). Eur J Intern Med 2008;19:e75–e77

    CrossRefPubMed
41. 41.↵
    2. Al-Sous MW,
    3. Bohlega S,
    4. Al-Kawi MZ, et al

    . Neurobrucellosis: clinical and neuroimaging correlation. AJNR Am J Neuroradiol 2004;25:395–401

    Abstract/FREE Full Text
42. 42.↵
    2. Bossi P,
    3. Tegnell A,
    4. Baka A, et al

    . BICHAT guidelines for the clinical management of viral encephalitis and bioterrorism-related viral encephalitis. Euro Surveill 2004;9:E21–22

    PubMed
43. 43.↵
    2. Misra UK,
    3. Kalita J

    . Overview: Japanese encephalitis. Prog Neurobiol 2010;91:108–20

    CrossRefPubMed
44. 44.↵
    2. Kalita J,
    3. Misra UK,
    4. Pandey S, et al

    . A comparison of clinical and radiological findings in adults and children with Japanese encephalitis. Arch Neurol 2003;60:1760–64

    CrossRefPubMedWeb of Science
45. 45.↵
    2. Kalita J,
    3. Misra UK

    . Comparison of CT scan and MRI findings in the diagnosis of Japanese encephalitis. J Neurol Sci 2000;174:3–8

    CrossRefPubMedWeb of Science
46. 46.↵
    2. Ali M,
    3. Safriel Y,
    4. Sohi J, et al

    . West Nile virus infection: MR imaging findings in the nervous system. AJNR Am J Neuroradiol 2005;26:289–97

    Abstract/FREE Full Text
47. 47.↵
    2. Leis AA,
    3. Stokic DS,
    4. Polk JL, et al

    . A poliomyelitis-like syndrome from West Nile virus infection. N Engl J Med 2002;347:1279–80

    CrossRefPubMedWeb of Science
48. 48.↵
    2. Sejvar JJ,
    3. Leis AA,
    4. Stokic DS, et al

    . Acute flaccid paralysis and West Nile virus infection. Emerg Infect Dis 2003;9:788–93

    CrossRefPubMedWeb of Science
49. 49.↵
    1. Dembek ZF

    2. Steele KE,
    3. Reed DS,
    4. Glass PJ, et al

    . Alphavirus encephalitides. In: Dembek ZF, ed. Medical Aspects of Biological Warfare. Washington, DC: Borden Institute; 2007:241–70
50. 50.↵
    2. Deresiewicz RL,
    3. Thaler SJ,
    4. Hsu L, et al

    . Clinical and neuroradiographic manifestations of eastern equine encephalitis. N Engl J Med 1997;336:1867–74

    CrossRefPubMedWeb of Science
51. 51.↵
    2. Lury K,
    3. Castillo M

    . Eastern equine encephalitis: CT and MRI findings in one case. Emerg Radiol 2004;11:46–48

    PubMed
52. 52.↵
    2. Silverman MA,
    3. Misasi J,
    4. Smole S, et al

    . Eastern equine encephalitis in children, Massachusetts and New Hampshire USA, 1970–2010. Emerg Infect Dis 2013;19:194–201

    CrossRefPubMed
53. 53.↵
    2. Alrajhi AA,
    3. Al-Semari A,
    4. Al-Watban J

    . Rift Valley fever encephalitis. Emerg Infect Dis 2004;10:554–55

    CrossRefPubMedWeb of Science
54. 54.↵
    2. Carod-Artal FJ,
    3. Wichmann O,
    4. Farrar J, et al

    . Neurological complications of dengue virus infection. Lancet Neurol 2013;12:906–19

    CrossRefPubMed
55. 55.↵
    2. Bhoi SK,
    3. Naik S,
    4. Kumar S, et al

    . Cranial imaging findings in dengue virus infection. J Neurol Sci 2014;342:36–41

    CrossRefPubMed
56. 56.↵
    2. Cam BV,
    3. Fonsmark L,
    4. Hue NB, et al

    . Prospective case-control study of encephalopathy in children with dengue hemorrhagic fever. Am J Trop Med Hyg 2001;65:848–51

    Abstract
57. 57.↵
    2. Chua KB

    . Nipah virus: a recently emergent deadly paramyxovirus. Science 2000;288:1432–35

    Abstract/FREE Full Text
58. 58.↵
    2. Luby SP,
    3. Gurley ES,
    4. Hossain MJ

    . Transmission of human infection with Nipah virus. Clin Infect Dis 2009;49:1743–48

    Abstract/FREE Full Text
59. 59.↵
    2. Lim CCT,
    3. Lee WL,
    4. Leo YS, et al

    . Late clinical and magnetic resonance imaging follow up of Nipah virus infection. J Neurol Neurosurg Psychiatry 2003;74:131–33

    Abstract/FREE Full Text
60. 60.↵
    2. Sarji SA,
    3. Abdullah BJ,
    4. Goh KJ, et al

    . MR imaging features of Nipah encephalitis. AJR Am J Roentgenol 2000;175:437–42

    CrossRefPubMedWeb of Science
61. 61.↵
    2. Morens DM,
    3. Fauci AS

    . Chikungunya at the door: déjà vu all over again? N Engl J Med 2014;371:885–87

    CrossRefPubMedWeb of Science
62. 62.↵
    2. Burt FJ,
    3. Rolph MS,
    4. Rulli NE, et al

    . Chikungunya: a re-emerging virus. Lancet 2012;379:662–71

    CrossRefPubMedWeb of Science
63. 63.↵
    2. Economopoulou A,
    3. Dominguez M,
    4. Helynck B, et al

    . Atypical chikungunya virus infections: clinical manifestations, mortality and risk factors for severe disease during the 2005–2006 outbreak on Réunion. Epidemiol Infect 2009;137:534–41

    CrossRefPubMedWeb of Science
64. 64.↵
    2. Gérardin P,
    3. Barau G,
    4. Michault A, et al

    . Multidisciplinary prospective study of mother-to-child chikungunya virus infections on the island of La Reunion. PLoS Med 2008;5:e60

    CrossRefPubMed
65. 65.↵
    1. Dembek ZF

    2. Whitehouse CA,
    3. Schmaljohn AL,
    4. Dembek ZF

    . Emerging infectious diseases and future threats. In: Dembek ZF, ed. Medical Aspects of Biological Warfare. Washington, DC: Borden Institute; 2007:579–607